Header Logo

Connection

John Somberg to Electrocardiography

Back to Details
This is a "connection" page, showing publications John Somberg has written about Electrocardiography.
John Somberg
Connection Strength
3.357
Electrocardiography
  1. A Rapid Method to Evaluate Cardiac Repolarization Changes: The Effect of Two Coffee Strengths on the QT Interval. Cardiology. 2015; 131(3):203-8.
    View in: PubMed
    Score: 0.460
  2. QT prolongation and serum sotalol concentration are highly correlated following intravenous and oral sotalol. Cardiology. 2010; 116(3):219-25.
    View in: PubMed
    Score: 0.331
  3. The dynamics of QT dispersion. Cardiology. 2009; 113(3):169-71.
    View in: PubMed
    Score: 0.297
  4. QT dispersion: still a useful measurement. Cardiology. 2009; 112(3):165-7.
    View in: PubMed
    Score: 0.287
  5. Ventricular repolarization spectra. Cardiology. 2008; 111(3):207-8.
    View in: PubMed
    Score: 0.283
  6. Hemodynamic and surface electrocardiographic effects of a new aqueous formulation of intravenous amiodarone. Am J Cardiol. 2002 Nov 01; 90(9):964-8.
    View in: PubMed
    Score: 0.193
  7. Usefulness of QT dispersion as an electrocardiographically derived index. Am J Cardiol. 2002 Feb 01; 89(3):291-4.
    View in: PubMed
    Score: 0.183
  8. Effect of intracoronary balloon inflation at percutaneous transluminal coronary angioplasty on QT dispersion. Am Heart J. 1998 Mar; 135(3):519-22.
    View in: PubMed
    Score: 0.140
  9. Relation of left ventricular mass and QT dispersion in patients with systematic hypertension. Am J Cardiol. 1997 Feb 15; 79(4):508-11.
    View in: PubMed
    Score: 0.130
  10. A randomized comparative study of the electrophysiological and electrocardiographic effects of isradipine vs verapamil. Acta Anaesthesiol Scand Suppl. 1993; 99:43-7.
    View in: PubMed
    Score: 0.098
  11. The additive effects of the active component of grapefruit juice (naringenin) and antiarrhythmic drugs on HERG inhibition. Cardiology. 2008; 110(3):145-52.
    View in: PubMed
    Score: 0.069
  12. Screening drugs for QT prolongation. Am J Ther. 2007 Sep-Oct; 14(5):419-20.
    View in: PubMed
    Score: 0.068
  13. QT prolongation and the antiarrhythmic efficacy of amiodarone. J Am Coll Cardiol. 1986 Jan; 7(1):142-7.
    View in: PubMed
    Score: 0.060
  14. The effect of magnesium sulfate on action potential duration and cardiac arrhythmias. Am J Ther. 2005 May-Jun; 12(3):218-22.
    View in: PubMed
    Score: 0.057
  15. Prolongation of QT interval and antiarrhythmic action of bepridil. Am Heart J. 1985 Jan; 109(1):19-27.
    View in: PubMed
    Score: 0.056
  16. Differential effect of glyburide (glibenclamide) and metformin on QT dispersion: a potential adenosine triphosphate sensitive K+ channel effect. Am J Cardiol. 2002 Nov 15; 90(10):1103-6.
    View in: PubMed
    Score: 0.048
  17. Arrhythmia therapy. Am J Ther. 2002 Nov-Dec; 9(6):537-42.
    View in: PubMed
    Score: 0.048
  18. Intravenous lidocaine versus intravenous amiodarone (in a new aqueous formulation) for incessant ventricular tachycardia. Am J Cardiol. 2002 Oct 15; 90(8):853-9.
    View in: PubMed
    Score: 0.048
  19. Influence of electrolyte abnormalities on interlead variability of ventricular repolarization times in 12-lead electrocardiography. Am J Ther. 2001 Mar-Apr; 8(2):117-22.
    View in: PubMed
    Score: 0.043
  20. Effect of angiotensin-converting enzyme therapy on QT interval dispersion. Am J Ther. 1999 Sep; 6(5):257-61.
    View in: PubMed
    Score: 0.039
  21. Prostaglandin E1 : electrophysiological safety in patients with congestive heart failure and peripheral arterial occlusive disease. The Alprostadil Investigators. Am J Ther. 1997 Nov-Dec; 4(11-12):401-4.
    View in: PubMed
    Score: 0.034
  22. Can nitroglycerin convert effort-induced angina in men into silent myocardial ischemia? Am J Cardiol. 1995 Aug 15; 76(5):337-9.
    View in: PubMed
    Score: 0.029
  23. The role of electrophysiologic testing in the selection of amiodarone therapy. J Clin Pharmacol. 1989 May; 29(5):429-35.
    View in: PubMed
    Score: 0.019
  24. The antiarrhythmic effects of d-sotalol. Am Heart J. 1987 Sep; 114(3):539-44.
    View in: PubMed
    Score: 0.017
  25. Evaluation of dosing interval and optimum dose of cibenzoline. J Clin Pharmacol. 1987 Sep; 27(9):666-72.
    View in: PubMed
    Score: 0.017
  26. Comparative efficacy of pirmenol and procainamide in a drug-resistant population with ventricular tachycardia. J Clin Pharmacol. 1987 Jul; 27(7):481-6.
    View in: PubMed
    Score: 0.017
  27. The treatment of ventricular rhythm disturbances. Am Heart J. 1986 Jun; 111(6):1162-76.
    View in: PubMed
    Score: 0.015
  28. Supraventricular tachyarrhythmias: their evaluation and therapy. Am Heart J. 1986 Jun; 111(6):1150-61.
    View in: PubMed
    Score: 0.015
  29. Antiarrhythmic efficacy of ethmozine in patients with ventricular tachycardia as determined by programmed electrical stimulation. Am Heart J. 1986 Apr; 111(4):661-6.
    View in: PubMed
    Score: 0.015
  30. Lorcainide therapy in a cardiac arrest population. Am Heart J. 1986 Apr; 111(4):648-53.
    View in: PubMed
    Score: 0.015
  31. Electrophysiologic evaluation of the antiarrhythmic effects of N-acetylprocainamide for ventricular tachycardia secondary to coronary artery disease. Am J Cardiol. 1985 Nov 15; 56(13):877-81.
    View in: PubMed
    Score: 0.015
  32. Antiarrhythmic effects of cibenzoline. Am Heart J. 1985 Apr; 109(4):827-33.
    View in: PubMed
    Score: 0.014
  33. Therapy for late post infarction ventricular tachycardia. Angiology. 1985 Mar; 36(3):181-90.
    View in: PubMed
    Score: 0.014
  34. Prolonged repolarization: a historical perspective. Am Heart J. 1985 Feb; 109(2):395-8.
    View in: PubMed
    Score: 0.014
  35. Long term lorcainide therapy guided by electrophysiology studies. Acta Cardiol. 1985; 40(6):621-36.
    View in: PubMed
    Score: 0.014
  36. Long-term lorcainide therapy in patients with ventricular tachycardia. Am Heart J. 1985 Jan; 109(1):33-40.
    View in: PubMed
    Score: 0.014
  37. Flecainide: long-term treatment using a reduced dosing schedule. Am J Cardiol. 1985 Jan 01; 55(1):79-83.
    View in: PubMed
    Score: 0.014
  38. Intravenous quinidine by intermittent bolus for electrophysiologic studies in patients with ventricular tachycardia. Am Heart J. 1984 Dec; 108(6):1437-42.
    View in: PubMed
    Score: 0.014
  39. The effect of bepridil, verapamil, and quinidine in the prevention of ventricular tachycardia induced by programmed electrical stimulation in the digitalized dog. Am Heart J. 1984 Nov; 108(5):1236-43.
    View in: PubMed
    Score: 0.014
  40. Lorcainide therapy for the high-risk patient post myocardial infarction. Am J Cardiol. 1984 Aug 13; 54(4):37B-42B.
    View in: PubMed
    Score: 0.014
  41. Evaluation of lorcainide in patients with symptomatic ventricular tachycardia. Am J Cardiol. 1984 Aug 13; 54(4):43B-48B.
    View in: PubMed
    Score: 0.014
  42. Antiarrhythmic action of bethanidine. Am J Cardiol. 1984 Aug 01; 54(3):343-6.
    View in: PubMed
    Score: 0.014
  43. New approaches to drug selection and serial drug testing. J Clin Pharmacol. 1984 Jul; 24(7):320-7.
    View in: PubMed
    Score: 0.014
  44. Pacing termination of ventricular tachycardia: influence of antiarrhythmic-slowed ectopic rate. Am Heart J. 1984 Apr; 107(4):638-43.
    View in: PubMed
    Score: 0.013
  45. Hypercalcemia, arrhythmia, and mood stabilizers. J Clin Psychopharmacol. 2000 Apr; 20(2):260-4.
    View in: PubMed
    Score: 0.010
  46. Lithium, hypercalcemia, and arrhythmia. J Clin Psychopharmacol. 1998 Oct; 18(5):420-3.
    View in: PubMed
    Score: 0.009
  47. Multicenter trial of sotalol for suppression of frequent, complex ventricular arrhythmias: a double-blind, randomized, placebo-controlled evaluation of two doses. J Am Coll Cardiol. 1986 Oct; 8(4):752-62.
    View in: PubMed
    Score: 0.004
  48. Comparative study of encainide and quinidine in the treatment of ventricular arrhythmias. J Am Coll Cardiol. 1986 Jan; 7(1):9-16.
    View in: PubMed
    Score: 0.004
  49. The influence of spinal cord transection on the capacity of digitoxin to induce cardiotoxicity. Arch Int Pharmacodyn Ther. 1974 Feb; 207(2):340-7.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.